Free shipping on all orders over $ 500

AM2394

Cat. No. M7567

All AbMole products are for research use only, cannot be used for human consumption.

AM2394 Structure
Size Price Availability Quantity
5mg USD 74 In stock
10mg USD 120 In stock
25mg USD 230 In stock
50mg USD 360 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

AM-2394, a structurally distinct glucokinase activator that displays a robust reduction in plasma glucose during an oral glucose tolerance test (OGTT) in ob/ob mice at a dose of 3 mg/kg. AM-2394 increases the affinity of glucokinase (GK) for glucose by approximately 10-fold, exhibits moderate clearance and good oral bioavailability in multiple animal models, and lowers glucose excursion following an oral glucose tolerance test in an ob/ob mouse model of diabetes. AM-2394 exhibits good-to-moderate cross species plasma clearance, volume of distribution, and oral bioavailability, allowing for further evaluation in animal models.

Protocol (for reference only)
Cell Experiment
Cell lines
Preparation method
Concentrations
Incubation time
Animal Experiment
Animal models Mice
Formulation
Dosages 3 mg/kg
Administration oral
Chemical Information
Molecular Weight 423.47
Formula C22H25N5O4
CAS Number 1442684-77-6
Form Solid
Solubility (25°C) DMSO 30 mg/mL
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
References

[1] Dransfield PJ, et al. ACS Med Chem Lett. Novel Series of Potent Glucokinase Activators Leading to the Discovery of AM-2394.

[2] Kohn TJ, et al. ACS Med Chem Lett. 5-Alkyl-2-urea-Substituted Pyridines: Identification of Efficacious Glucokinase Activators with Improved Properties

Related Glucokinase (GK) Products
LY2608204

LY2608204 activates glucokinase (GK) with EC50 of 42 nM.

Dorzagliatin

Dorzagliatin (HMS-5552, RO-5305552, Sinogliatin) is a glucokinase (GK) activator, which improves glycaemic control and pancreatic β-cell function for type 2 diabetes.

AZD1656

AZD1656 is a potent, selective and orally active glucokinase (GK) activator, with an EC50 of 60 nM.

Cadisegliatin (TTP-399)

Cadisegliatin (TTP-399) is a potential, orally active liver-selective glucokinase (GK) activator. Cadisegliatin has antihyperglycaemic activity. Cadisegliatin can be used for the research of type 2 diabetes.

  Catalog
Abmole Inhibitor Catalog




Keywords: AM2394 supplier, Glucokinase (GK), inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2026 AbMole BioScience. All Rights Reserved.